InnovaDerma PLC (the “Company”), a UK developer of ‘at-home’ and clinically-proven treatments for hair loss, hair care, selftanning
and skin rejuvenation today announces that its entire issued share capital consisting of 10,318,535 ordinary shares of
€0.10 each (the “Ordinary Shares”) will today be admitted to the standard segment of the Official List of the UK Listing
Authority and to trading on the Main Market for listed securities of the London Stock Exchange (together “Admission”).
Dealings are expected to commence at 8:00 a.m. under the TIDM code “IDP” (ISIN: GBOOBT9PTW34). The Ordinary Shares
already trade under the TIDM code “MLIDP” on the Marché Libre operated by Euronext Paris SA. It is the Company’s
intention to delist its Ordinary Shares from the Marché Libre.
The Prospectus and Supplementary Prospectus published by the Company on 25 July 2016 and on 2 September 2016,
respectively, in connection with this Admission can be found on the Company’s website at www.innovadermaplc.com.
Mr. HarisChaudhry, Executive Chairman and Founder of InnovaDerma said:
“With our strong brands, which have an international presence, and the excellent progress made by the Group, the
opportunities that lie ahead make this an exciting time for us to bring InnovaDerma to the London Stock Exchange.”
Haris Chaudhry/Joe Bayer +61 (0)3 9111 0071
Claire Noyce/Niall Pearson
+44 (0)203 764 2341 / 2343
Shan Shan Willenbrock
+44 (0)20 7930 0777
InnovaDerma PLC specialises in the research, manufacture and marketing of clinically proven products in hair loss, antiageing
and beauty sectors. InnovaDerma has presence in the United Kingdom, Australia, New Zealand, Philippines, South
Africa, Hong Kong and South Korea.